Package 81033-123-16

Brand: gabapentin

Generic: gabapentin
NDC Package

Package Facts

Identity

Package NDC 81033-123-16
Digits Only 8103312316
Product NDC 81033-123
Product ID 81033-123_4470a571-3213-9849-e063-6394a90a39b2
Description

473 mL in 1 BOTTLE (81033-123-16)

Marketing

Marketing Status
Marketed Since 2025-09-01
Brand gabapentin
Generic gabapentin
Sample Package No

Linked Drug Pages (1)

Gabapentin ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "4470a571-3213-9849-e063-6394a90a39b2", "openfda": {"nui": ["N0000008486"], "upc": ["0381033123165"], "unii": ["6CW7F3G59X"], "rxcui": ["283523"], "spl_set_id": ["4470a567-93a6-a293-e063-6394a90affc1"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Kesin Pharma Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "473 mL in 1 BOTTLE (81033-123-16)", "package_ndc": "81033-123-16", "marketing_start_date": "20250901"}], "brand_name": "Gabapentin", "product_id": "81033-123_4470a571-3213-9849-e063-6394a90a39b2", "dosage_form": "SOLUTION", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "81033-123", "generic_name": "Gabapentin", "labeler_name": "Kesin Pharma Corporation", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Gabapentin", "active_ingredients": [{"name": "GABAPENTIN", "strength": "250 mg/5mL"}], "application_number": "ANDA091286", "marketing_category": "ANDA", "marketing_start_date": "20250806", "listing_expiration_date": "20261231"}